Publicaciones en colaboración con investigadores/as de Instituto de Investigaciones Biomédicas Alberto Sols (2)

2024

  1. Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy

    Behavioral and Brain Functions , Vol. 20, Núm. 1

2018

  1. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease

    GLIA, Vol. 66, Núm. 8, pp. 1752-1762